Slowly the arm of the law is catching up on those responsible for
the Dengvaxia scandal that has rocked the country when the countrywide
anti-dengue campaign was set into motion during the administration of former
President Benigno “Noynoy” Aquino III.
The Department of Justice (DOJ) charged former Secretary of Health and current Rep.
Janette Garin (Iloilo, 1st District) and nine others on reckless imprudence
resulting to homicide over the controversial anti-Dengue vaccine Dengvaxia.
In their press release, the DOJ
said that state prosecutors found probable cause to indict Garin, former Health
secretary, and officials of the Department of Health, Food and Drug
Administration, Research Institute for Tropical Medicine and Sanofi Pasteur
Inc. for reckless imprudence resulting to homicide.
 |
| Then DOH Secretary janette Garin with former President BS Aquino III, during the mass vaccination of Dengue launch. (photo credit to owner) |
“The Panel [of prosecutors] concluded
that the accomplishment of the procurement process for the Dengvaxia vaccine,
with undue haste, within a limited timeframe, and despite the red flags known
to Garin and other respondents, amounted to reckless imprudence,” DOJ said.
DOJ has reached the conclusion that the so-called miracle vaccine
against Dengue was purchased by the Aquino administration and rolled out for
use even though clinical trials for the vaccine were not yet completed.
“The panel found that there was no showing that the Dengvaxia
vaccine had undergone [World Health Organization] prequalification at the time
the FDA issued the [Certificate of Product Registration,” the release provided
by Justice Assistant Secretary Neal Bainto read.
DOJ Prosecutors also said they found that the accused did not
fully inform, and obtain the consent of, those who were vaccinated and their
respective families of the “nature and risks” of Dengvaxia.
There was also no physical examination or health assessment of the
kids before the inoculation of the vaccine, the DOJsaid.
Sanofi not off the hook
The DOJ indicted also the president of Sanofi Pasteur for
violating the Consumer Act of the Philippines "for manufacturing the
Dengvaxia vaccine which poses certain risks to seronegatives, or to those who
have not previously contracted the Dengue disease."
“The Panel found that Sanofi indirectly admitted that Dengvaxia is
a defective product due to the risk it poses to seronegatives,” it said.
Said act is in direct violation of the Article 97 of Republic Act
7394 or the Consumer Act of the Philippines that holds that a product is
defective if “it does not offer the safety rightfully expected of it,”
including “the use and hazards reasonably expected of it.”
State prosecutors “found that the circumstances surrounding the
dispensation of the Dengvaxia vaccine made the same a mislabelled drug and held
liable the President of Sanofi and four of its other officers or directors for
violating the same act,” the statement read.
What can you say about this?
Share
us your thoughts by simply leaving on the comment section below. For more news
updates, feel free to visit our site often.
Stay
updated with today's relevant news and trends by hitting the LIKE button.
Thanks
for dropping by and reading this post.
Report from PhilStar
Disclaimer: Contributed
articles does not reflect the view of THE PH CHRONICLES.
This website cannot guarantee the legitimacy of some of the information
contributed to us. You may do additional research if you find some information
doubtful. No part of this article maybe reproduced without permission
from this website.
0 Comments